.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Novartis
Deloitte
AstraZeneca
Fish and Richardson
Queensland Health
Farmers Insurance
Teva
US Army
Chubb

Generated: June 24, 2017

DrugPatentWatch Database Preview

THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Theophylline 0.16% And Dextrose 5% In Plastic Container, and when can generic versions of Theophylline 0.16% And Dextrose 5% In Plastic Container launch?

Theophylline 0.16% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in two NDAs.

The generic ingredient in THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list27
Clinical Trials: see list104,403
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed

Pharmacology for Tradename: THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Ingredient-typeXanthines
Drug ClassMethylxanthine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019826-003Aug 14, 1992APRXYesYes► Subscribe► Subscribe
B Braun
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019083-003Nov 7, 1984DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
UBS
QuintilesIMS
Baxter
Mallinckrodt
US Department of Justice
Citi
US Army
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot